Skip to search formSkip to main contentSkip to account menu
‘First World Health Care at Third World Prices’: Globalization, Bioethics and Medical Tourism
  • L. Turner
  • Medicine, Political Science
  • 30 August 2007
TLDR
Reductions in health benefits offered by states and employers will likely increase the number of individuals looking for affordable medical care in a global market of privatized, commercial health care delivery.
View on Springer
Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.
View on PubMed
Promoting medical tourism to India: messages, images, and the marketing of international patient travel.
View on PubMed
Quality in health care and globalization of health services: accreditation and regulatory oversight of medical tourism companies.
  • L. Turner
  • Medicine, Business
    International journal for quality in health care…
  • 1 February 2011
TLDR
Establishing high standards for the operation of medical tourism companies should reduce risks facing patients when they travel abroad for health care, as well as protect clients from financial losses.
View on PubMed
Clear up this stem-cell mess
Confusion about mesenchymal stem cells is making it easier for people to sell unproven treatments, warn Douglas Sipp, Pamela G. Robey and Leigh Turner.Confusion about mesenchymal stem cells is making…
View on Springer
“Medical Tourism” and the Global Marketplace in Health Services: U.S. Patients, International Hospitals, and the Search for Affordable Health Care
  • L. Turner
  • Medicine, Political Science
    International journal of health services…
  • 1 July 2010
TLDR
The emergence of a global market in health services will have profound consequences for health insurance, delivery of health services, patient-physician relationships, publicly funded health care, and the spread of medical consumerism.
View on SAGE
Medical tourism: family medicine and international health-related travel.
  • L. Turner
  • Medicine, Political Science
    Canadian family physician Medecin de famille…
  • 1 October 2007
TLDR
This study highlights the need to shorten waiting lists for medical interventions such as hip and knee replacements, spinal surgery, and ophthalmologic procedures.
View on PubMed
The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions
  • L. Turner
  • Business
    Perspectives in biology and medicine
  • 22 May 2018
TLDR
An overview of this marketplace is provided, advertising techniques companies use to draw clients and legitimate marketing claims are examined, and the roles the Food and Drug Administration and other agencies are supposed to play in regulating the direct-to-consumer marketplace for stem cell interventions are summarized.
View on PubMed
Public Goods, Private Goods
View on Springer
Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel
  • L. Turner
  • Business, Medicine
    Globalization and health
  • 14 October 2011
TLDR
A detailed empirical analysis of websites of medical tourism companies that were based in Canada but exited the marketplace and are now inoperative reveals a fluid marketplace, with many medical tourism firms exiting this industry.
View on Springer
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License